Welcome to Sagentia at AACC 2020

Who are we and what do we do? Sagentia is a R&D Consultancy with a 30-year history delivering innovative diagnostic platforms to our international partners. We blend scientific first principles and human factors to augment our cartridge-led development and are privileged to have developed the first CLIA waived molecular Dx cartridge in 2015. We believe that understanding the user in consideration with technical excellence and commercial viability is the key to improving patient outcomes and employ over 150 scientists, engineers and design thinkers to enable this.

We benefit our partners through:

  • A user centred, cartridge-led approach that accelerates your timelines
  • In-house prototyping to rapidly de-risk and iterate your microfluidic platform
  • Access to industry expert diagnostic developers to extend your team
  • Turn-key ISO:13485 development solutions

Contact us to find out more

Watch our talk at AACC “Getting your new assay to point of care ­– optimizing consumable and instrument design”

Outline of the talk

Nick Collier and Steve Brown share top 9 learnings from many PoC diagnostic assay development projects. They will highlight some key considerations, things to avoid and where the focuses should be to ensured getting to marketing faster and at the right price point.

Meet our AACC team

Please get in touch with them if you’d like to arrange a meeting

Nick Collier

Chief Technology Officer

Nicholas.Collier@sagentia.com

Steve Brown

Senior Engineer & Team Leader

Stephen.Brown@sagentia.com

Carl Hewett

Design & Innovation Manager

Carl.Hewett@sagentia.com

Stefanie Settlin

New Business Development

Stefanie.Settlin@sagentia.com

Josh Jackson

Medical Business Development

Josh.Jackson@sagentia.com

Watch our latest webinar and read our latest white papers, case studies and articles

Get in touch